SEC 13F Intelligence

Decheng Capital Management III (Cayman), LLC / PHAT

Decheng Capital Management III (Cayman), LLC’s Phathom Pharmaceuticals Inc Position

Does Decheng Capital Management III (Cayman), LLC own Phathom Pharmaceuticals Inc (PHAT)? Yes — 850.0K shares worth $9M (+2.94% of its 13F portfolio) as of Q4 2023.

Position Value
$9M
Q4 2023
Shares
850.0K
% of Portfolio
+2.94%
Quarters Held
3
currently held

Position History PHAT

Reported value by quarter
Q2 ’23: $12MQ2 ’23Q3 ’23: $9MQ3 ’23Q4 ’23: $9MQ4 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2023850.0K$9M+2.94%
Q3 2023850.0K$9M+2.82%
Q2 2023850.0K$12M+3.82%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Decheng Capital Management III (Cayman), LLC’s full portfolio or all institutional holders of PHAT.